Rx News
Together Rx Access Appoints Pfizer's Gary Pelletier to Chairman of Board of Managers
September 18, 2013
ALEXANDRIA, Va.--The Together Rx Access® Program, a prescription savings program sponsored by many of the nation's leading pharmaceutical companies, appointed Gary Pelletier as Chairman of the Board of Managers. Mr. Pelletier currently serves as Director and Team Leader for Pfizer Helpful Answers®, a family of programs to help the uninsured and underinsured get access to Pfizer medicines for free or at a savings. He previously served as Vice Chairman of the Board of Together Rx Access.
"Together Rx Access is honored and privileged to have Gary lead us in our mission to provide better access to medicines for America's uninsured," said Roba Whiteley, executive director of Together Rx Access. "In his role at Pfizer, Gary has been a champion of programs that provide better access to medicines. His leadership and vision will guide our continuing commitment to helping uninsured Americans access the prescription medicines they need to stay healthy and treat chronic conditions which is the best way to manage overall healthcare costs."
Prior to joining Pfizer, Mr. Pelletier was a Project Leader with The Boston Consulting Group where he helped develop business strategies for clients across numerous industries, including healthcare and pharmaceuticals. He also has extensive previous experience in advertising, having held senior account management positions at several agencies in New York, including Saatchi & Saatchi and Ogilvy & Mather.
Mr. Pelletier received his Master's Degree in Business Administration from The Stanford University Graduate School of Business where he also earned a Certificate in Public Management. He holds a Bachelor of Arts Degree from Brandeis University.
News Topics
Top News Articles
- New Parkinson's Disease Drug Approved
May 4, 2017 - Hypertension Guidelines Consensus Statement
April 1, 2017 - Novel Abuse-Deterrent Morphine Approved
March 1, 2017 - New Heart Failure Guidelines
February 1, 2017 - New Eczema Drug Approved
January 1, 2017